Skip to main content Accessibility help
×
Home
Hostname: page-component-ffbbcc459-ms7tc Total loading time: 0.622 Render date: 2022-03-05T12:17:51.018Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Unrecognised myocardial infarction in patients with schizophrenia

Published online by Cambridge University Press:  13 January 2015

Jimmi Nielsen*
Affiliation:
Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Jacob Juel
Affiliation:
Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
Karam Sadoon Majeed Al Zuhairi
Affiliation:
Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
Rasmus Friis
Affiliation:
Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark
Claus Graff
Affiliation:
Department of Health Science and Technology, Aalborg University, Aalborg, Denmark
Jørgen Kim Kanters
Affiliation:
Laboratory of Experimental Cardiology, Department of Biomedical Sciences, Copenhagen University, København, Denmark Department of Cardiology, Herlev & Gentofte University Hospitals, Copenhagen, Denmark
Svend Eggert Jensen
Affiliation:
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
*
Jimmi Nielsen, Centre for Schizophrenia, Aalborg University Hospital, Psychiatry, Brandevej 5, 9220 Aalborg Øst, Denmark. Tel: +4597643565; Fax: +4597643566; E-mail: jin@rn.dk

Abstract

Objective

Schizophrenia is associated with a reduction of the lifespan by 20 years, with type II diabetes and cardiovascular disease contributing the most to the increased mortality. Unrecognised or silent myocardial infarction (MI) occurs in ~30% of the population, but the rates of unrecognised MI in patients with schizophrenia have only been sparsely investigated.

Method

Electrocardiograms (ECG) from three psychiatric hospitals in Denmark were manually interpreted for signs of previous MI. Subsequently, ECGs were linked to the National Patient Registry in order to determine whether patients had a diagnosis consistent with previous MI.

Results

A total of 937 ECGs were interpreted, 538 men (57.4%) and 399 women (42.6%). Mean age at the time of ECG acquisition was 40.6 years (95% CI: 39.7–41.5, range: 15.9–94.6). We identified 32 patients with positive ECG signs of MIs. Only two of these patients had a diagnosis of MI in the National Patient Registry. An additional number of eight patients had a diagnosis of MI in the Danish National Patient Registry, but with no ECG signs of previous MI. This means that 30 out of 40 (75%) MIs were unrecognised. Only increasing age was associated with unrecognised MI in a stepwise multiple logistic regression model compared with patients with no history of MI, OR: 1.03 per year of age, 95% CI: 1.00–1.06, p=0.021.

Conclusion

Unrecognised MI is common among patients with schizophrenia and may contribute to the increased mortality found in this patient group.

Type
Original Articles
Copyright
© Scandinavian College of Neuropsychopharmacology 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Uggerby, P, Nielsen, RE, Correll, CU, Nielsen, J. Characteristics and predictors of long-term institutionalization in patients with schizophrenia. Schizophr Res 2011;131:120126.CrossRefGoogle ScholarPubMed
2. Correll, CU, Nielsen, J. Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed? Acta Psychiatrica Scandinavica 2010;122:341344.CrossRefGoogle ScholarPubMed
3. De Hert, MA, van Winkel, R, Van Eyck, D et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 2006;83:8793.CrossRefGoogle ScholarPubMed
4. McEvoy, JP, Meyer, JM, Goff, DC et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005;80:1932.CrossRefGoogle Scholar
5. Vancampfort, D, Knapen, J, Probst, M, Scheewe, T, Remans, S, De Hert, M. A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand 2012;125:352362.CrossRefGoogle ScholarPubMed
6. Roick, C, Fritz-Wieacker, A, Matschinger, H et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007;42:268276.CrossRefGoogle ScholarPubMed
7. Nielsen, J, Graff, C, Kanters, JK, Toft, E, Taylor, D, Meyer, JM. Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs 2011;25:473490.CrossRefGoogle Scholar
8. Nielsen, J, Skadhede, S, Correll, CU. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients. Neuropsychopharmacology 2010;35:19972004.CrossRefGoogle ScholarPubMed
9. Nielsen, J, Munk-Jorgensen, P, Skadhede, S, Correll, CU. Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study. J Clin Psychiatry 2011;72:140143.CrossRefGoogle ScholarPubMed
10. Marder, SR, Essock, SM, Miller, AL et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004;161:13341349.CrossRefGoogle ScholarPubMed
11. Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:11231131.CrossRefGoogle Scholar
12. Laursen, TM, Nordentoft, M. Heart disease treatment and mortality in schizophrenia and bipolar disorder – changes in the Danish population between 1994 and 2006. J Psychiatr Res 2011;45:2935.CrossRefGoogle Scholar
13. Kannel, WB. Silent myocardial ischemia and infarction: insights from the Framingham Study. Cardiol Clin 1986;4:583591.Google ScholarPubMed
14. Kannel, WB, Abbott, RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 1984;311:11441147.CrossRefGoogle ScholarPubMed
15. Sigurdsson, E, Thorgeirsson, G, Sigvaldason, H, Sigfusson, N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med 1995;122:96102.CrossRefGoogle ScholarPubMed
16. Valensi, P, Lorgis, L, Cottin, Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis 2011;104:178188.CrossRefGoogle ScholarPubMed
17. Arenja, N, Mueller, C, Ehl, NF et al. Prevalence, extent, and independent predictors of silent myocardial infarction. Am J Med 2013;126:515522.CrossRefGoogle ScholarPubMed
18. Niakan, E, Harati, Y, Rolak, LA, Comstock, JP, Rokey, R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 1986;146:22292230.CrossRefGoogle ScholarPubMed
19. Rosenthal, SH, Porter, KA, Coffey, B. Pain insensitivity in schizophrenia. Case report and review of the literature. Gen Hosp Psychiatry 1990;12:319322.CrossRefGoogle ScholarPubMed
20. Apter, JT. The “silent” acute abdomen of schizophrenia. J Med Soc N J 1981;78:679680.Google ScholarPubMed
21. Fishbain, DA. Pain insensitivity in psychosis. Ann Emerg Med 1982;11:630632.CrossRefGoogle ScholarPubMed
22. Hooley, JM, Delgado, ML. Pain insensitivity in the relatives of schizophrenia patients. Schizophr Res 2001;47:265273.CrossRefGoogle Scholar
23. Marchand, WE. Occurrence of painless myocardial infarction in psychotic patients. N Engl J Med 1955;253:5155.CrossRefGoogle Scholar
24. Bonnot, O, Anderson, GM, Cohen, D, Willer, JC, Tordjman, S. Are patients with schizophrenia insensitive to pain? A reconsideration of the question. Clin J Pain 2009;25:244252.CrossRefGoogle Scholar
25. Singh, MK, Giles, LL, Nasrallah, HA. Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 2006;12:90102.CrossRefGoogle ScholarPubMed
26. Mors, O, Perto, GP, Mortensen, PB. The Danish psychiatric Central Research Register. Scand J Public Health 2011;39:5457.CrossRefGoogle ScholarPubMed
27. Thygesen, K, Alpert, JS, White, HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:25252538.Google ScholarPubMed
28. Andersen, TH, Kappers, D, Sneider, B, Uggerby, P, Nielsen, J. Involuntary treatment of schizophrenia patients 2004–2010 in Denmark. Acta Psychiatr Scand 2014;129:312319.CrossRefGoogle ScholarPubMed
29. Ammar, KA, Kors, JA, Yawn, BP, Rodeheffer, RJ. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am Heart J 2004;148:277284.CrossRefGoogle Scholar
30. Thygesen, K, Alpert, JS, Jaffe, AS, Simoons, ML, Chaitman, BR, White, HD. Third universal definition of myocardial infarction. Eur Heart J 2012;33:25512567.CrossRefGoogle ScholarPubMed
31. Rasoul, S, de Boer, MJ, Suryapranata, H et al. Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome. Neth Heart J 2007;15:286290.CrossRefGoogle ScholarPubMed
32. Yano, K, MacLean, CJ. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. Arch Intern Med 1989;149:15281532.CrossRefGoogle ScholarPubMed
33. Uggerby, P, Ostergaard, SD, Roge, R, Correll, CU, Nielsen, J. The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good. Dan Med J 2013;60:A4578.Google Scholar
34. Madsen, M, Davidsen, M, Rasmussen, S, Abildstrom, SZ, Osler, M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003;56:124130.CrossRefGoogle Scholar
35. Nasrallah, HA, Meyer, JM, Goff, DC et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006;86:1522.CrossRefGoogle ScholarPubMed
36. Burgess, DC, Hunt, D, Li, L et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 2010;31:9299.CrossRefGoogle ScholarPubMed
37. Scirica, BM. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. Circulation 2013;127:965967.CrossRefGoogle ScholarPubMed
38. Sejil, S, Janand-Delenne, B, Avierinos, JF et al. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. Diabet Med 2006;23:11861191.CrossRefGoogle ScholarPubMed
25
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Unrecognised myocardial infarction in patients with schizophrenia
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Unrecognised myocardial infarction in patients with schizophrenia
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Unrecognised myocardial infarction in patients with schizophrenia
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *